Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06239194 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 115 participants |
| Active Locations | 6 sites in the US |
| Sponsor | ModeX Therapeutics, An OPKO Health Company |
| Last Updated on CT.gov | June 22, 2025 (Jun 22, 2025) |
As of March 2, 2026: Clinical trial NCT06239194 is currently recruiting participants. This clinical trial study for advanced solid tumors is actively seeking new participants at 6 locations across the United States. The study is sponsored by ModeX Therapeutics, An OPKO Health Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06239194 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06239194 was last updated Jun 22, 2025 (June 22, 2025). HelloStudys verifies this status automatically.